Literature DB >> 10228865

Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation?

S Kikuchi1, O Tsutsumi, N Kobayashi, H Tsukamoto, H Shimao, Y Sakakibara, Y Hiki, A Kakita.   

Abstract

BACKGROUND/AIMS: Gastrojejunostomy is the procedure of choice for patients with obstruction or stenosis of the gastric outlet or duodenum. However, the palliative benefits of this procedure in gastric cancer remain uncertain. Thus, the present study was performed to address this problem.
METHODOLOGY: In the present study, 52 patients who had undergone gastrojejunostomy for unresectable cancer of the gastric antrum at Kitasato University Hospital and Kitasato University East Hospital in Japan between 1972 and 1994 were examined.
RESULTS: The median survival time in these 52 patients was 5.0 months. The duration of palliation ranged from 0-13 months, with an average of 2.8 months. No significant difference between clinicopathologic factors and duration of palliation was found and location of tumor was the only independent prognostic factor (coefficient: 0.890; hazard ratio: 2.435).
CONCLUSIONS: Although gastrojejunostomy for unresectable cancer of the gastric antrum is the procedure most often chosen at laparotomy, the palliative benefits of gastrojejunostomy do not sufficiently compensate for the patients' limited post-operative survival and quality of life.

Entities:  

Mesh:

Year:  1999        PMID: 10228865

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  14 in total

Review 1.  A systematic review of surgery for non-curative gastric cancer.

Authors:  Alyson L Mahar; Natalie G Coburn; Simron Singh; Calvin Law; Lucy K Helyer
Journal:  Gastric Cancer       Date:  2011-10-28       Impact factor: 7.370

Review 2.  Quality of life: A critical outcome for all surgical treatments of gastric cancer.

Authors:  Michael D McCall; Peter J Graham; Oliver F Bathe
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

3.  Gastrojejunostomy as induction treatment for S-1-based chemotherapy in patients with incurable gastric cancer.

Authors:  Manabu Ohashi; Tatsuo Kanda; Masaki Hirota; Takashi Kobayashi; Kazuhito Yajima; Shin-ichi Kosugi; Katsuyoshi Hatakeyama
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

4.  Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions.

Authors:  Tetsuo Ikeda; Naoyuki Ueda; Yusuke Yonemura; Kohjiro Mashino; Akira Kabashima; Kiminori Watanabe; Kyuzo Fujii; Hideya Tashiro; Hisanobu Sakata
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

Review 5.  Modern management of cancer-related intestinal obstruction.

Authors:  M P Davis; C Nouneh
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

6.  Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life.

Authors:  Volker Kahlke; Beate Bestmann; Andreas Schmid; Julius Marek Doniec; Thomas Küchler; Bernd Kremer
Journal:  World J Surg       Date:  2004-03-17       Impact factor: 3.352

7.  Role of gastric bypass in patients with unresectable advanced carcinoma of stomach.

Authors:  Nagarjuna V Maturu; Dinker R Pai; Vishnu N R Prasad
Journal:  Indian J Surg       Date:  2008-12-23       Impact factor: 0.656

8.  Role of gastric bypass in patients with unresectable advanced carcinoma of stomach.

Authors:  Nagarjuna V Maturu; Dinker R Pai; Vishnu N R Prasad
Journal:  Indian J Surg       Date:  2008-01-28       Impact factor: 0.656

Review 9.  Modern management of cancer-related intestinal obstruction.

Authors:  M P Davis; C Nouneh
Journal:  Curr Pain Headache Rep       Date:  2001-06

10.  Enteral stenting in 21 patients with malignant gastroduodenal obstruction.

Authors:  Tjun Tang; Mike Allison; Irene Dunkley; Phil Roberts; Richard Dickinson
Journal:  J R Soc Med       Date:  2003-10       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.